- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/18 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
Patent holdings for IPC class C07D 265/18
Total number of patents in this class: 110
10-year publication summary
|
5
|
8
|
8
|
2
|
3
|
1
|
8
|
4
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Lonza Ltd. | 586 |
7 |
| University of Southern California | 2134 |
4 |
| GABA Therapeutics Inc. | 7 |
4 |
| F. Hoffmann-La Roche AG | 7819 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| Syngenta Participations AG | 1516 |
3 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 128 |
3 |
| Lonza Guangzhou Research and Development Center Ltd. | 7 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 277 |
3 |
| Yale University | 2543 |
3 |
| Shanghai Zhimeng Biopharma Inc. | 34 |
3 |
| Genentech, Inc. | 4110 |
2 |
| Afton Chemical Corporation | 498 |
2 |
| Archimica GmbH | 8 |
2 |
| D.E. Shaw Research, LLC | 98 |
2 |
| Theaprin Pharmaceuticals Inc. | 32 |
2 |
| Ultimorphix Technologies B.V. | 11 |
2 |
| University of Tennessee Research Foundation | 764 |
2 |
| Laurus Labs Limited | 97 |
2 |
| Jiangsu Puxin Pharmaceutical Co., Ltd. | 6 |
2 |
| Other owners | 53 |